首页 > 最新文献

Techniques and Innovations in Gastrointestinal Endoscopy最新文献

英文 中文
Does the Absence of Contrast Passage Into the Duodenum During Intraoperative Cholangiogram Truly Predict Choledocholithiasis? 术中胆管造影没有造影剂进入十二指肠真的能预测胆总管结石吗?
IF 2.4 Q3 Medicine Pub Date : 2023-01-01 DOI: 10.1016/j.tige.2023.05.002
Vishal Kaila , Daisha J. Cipher , Robert Anderson , Rushikesh Shah , Hemangi Kale

Background and Aims

The absence of contrast passage to the duodenum is frequently encountered during an intraoperative cholangiogram (IOC), and patients with this finding are suspected of having choledocholithiasis. This study was conducted to determine the positive predictive value (PPV) of the absence of contrast passage during IOC and identify predictors, if any, that increase the pretest probability of choledocholithiasis in these patients.

Methods

All laparoscopic cholecystectomies with IOCs between September 1, 2019, and September 1, 2021, at a tertiary medical center were reviewed to identify those with abnormal cholangiograms due to only the lack of contrast passage to the duodenum. Patient demographic information, pre- and postoperative laboratory results, and radiographic studies were recorded. Postprocedural clinical outcomes including endoscopic ultrasound (EUS) and endoscopic retrograde cholangiopancreatography (ERCP) findings were tabulated to determine the presence of choledocholithiasis. Patient factors and outcomes were compared between a cohort that was found to have choledocholithiasis vs those who were not. Finally, multiple logistic regression was performed to identify predictors of choledocholithiasis.

Results

Of 320 IOCs, 31(9.7% of all abnormal IOCs) showed the lack of contrast passage in the duodenum as the only abnormality. The PPV of an IOC with the lack of contrast in the duodenum was 29%. Preoperative bilirubin levels, postoperative aspartate aminotransferase levels, and postoperative alanine transaminase levels were significant predictors of choledocholithiasis in this group of patients.

Conclusions

The lack of contrast passage to the duodenum as the sole finding of an abnormal IOC has poor PPV for choledocholithiasis. Thus, it is reasonable to consider using less invasive modalities such as EUS and/or magnetic resonance cholangiopancreatography before ERCP in these patients.

背景和目的在术中胆道造影(IOC)中经常遇到十二指肠造影剂通道缺失的情况,有此发现的患者被怀疑患有胆总管结石。本研究旨在确定IOC期间造影剂通道缺失的阳性预测值(PPV),并确定增加这些患者胆总管结石检测前概率的预测因素(如果有的话)。方法回顾2019年9月1日至2021年9月31日在三级医疗中心进行的所有腹腔镜胆囊切除术,以确定那些仅因缺乏通往十二指肠的造影剂通道而导致胆管造影异常的患者。记录患者人口统计信息、术前和术后实验室结果以及放射学研究。术后临床结果包括内镜超声(EUS)和内镜逆行胰胆管造影(ERCP)检查结果,以确定胆总管结石的存在。比较发现有胆总管结石的队列与未发现胆总管结石队列的患者因素和结果。最后,进行多元逻辑回归以确定胆总管结石的预测因素。结果320个IOC中,31个(占所有异常IOC的9.7%)显示十二指肠造影剂通道缺乏是唯一的异常。十二指肠造影剂缺乏的IOC的PPV为29%。术前胆红素水平、术后天冬氨酸转氨酶水平和术后丙氨酸转氨酶水平是该组患者胆总管结石的重要预测因素。结论缺乏十二指肠造影剂通道作为异常IOC的唯一发现,对胆总管结石的PPV较差。因此,在对这些患者进行ERCP之前,考虑使用侵入性较小的方法,如EUS和/或磁共振胰胆管造影是合理的。
{"title":"Does the Absence of Contrast Passage Into the Duodenum During Intraoperative Cholangiogram Truly Predict Choledocholithiasis?","authors":"Vishal Kaila ,&nbsp;Daisha J. Cipher ,&nbsp;Robert Anderson ,&nbsp;Rushikesh Shah ,&nbsp;Hemangi Kale","doi":"10.1016/j.tige.2023.05.002","DOIUrl":"https://doi.org/10.1016/j.tige.2023.05.002","url":null,"abstract":"<div><h3>Background and Aims</h3><p><span>The absence of contrast passage to the duodenum is frequently encountered during an intraoperative </span>cholangiogram<span> (IOC), and patients with this finding are suspected of having choledocholithiasis. This study was conducted to determine the positive predictive value (PPV) of the absence of contrast passage during IOC and identify predictors, if any, that increase the pretest probability of choledocholithiasis in these patients.</span></p></div><div><h3>Methods</h3><p><span>All laparoscopic cholecystectomies<span> with IOCs between September 1, 2019, and September 1, 2021, at a tertiary medical center were reviewed to identify those with abnormal cholangiograms due to only the lack of contrast passage to the duodenum. Patient demographic information, pre- and postoperative laboratory results, and radiographic studies were recorded. Postprocedural clinical outcomes including endoscopic ultrasound (EUS) and </span></span>endoscopic retrograde cholangiopancreatography<span> (ERCP) findings were tabulated to determine the presence of choledocholithiasis. Patient factors and outcomes were compared between a cohort that was found to have choledocholithiasis vs those who were not. Finally, multiple logistic regression was performed to identify predictors of choledocholithiasis.</span></p></div><div><h3>Results</h3><p>Of 320 IOCs, 31(9.7% of all abnormal IOCs) showed the lack of contrast passage in the duodenum as the only abnormality. The PPV of an IOC with the lack of contrast in the duodenum was 29%. Preoperative bilirubin<span> levels, postoperative aspartate aminotransferase levels, and postoperative alanine transaminase levels were significant predictors of choledocholithiasis in this group of patients.</span></p></div><div><h3>Conclusions</h3><p>The lack of contrast passage to the duodenum as the sole finding of an abnormal IOC has poor PPV for choledocholithiasis. Thus, it is reasonable to consider using less invasive modalities such as EUS and/or magnetic resonance cholangiopancreatography before ERCP in these patients.</p></div>","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49765285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hybrid Endoscopic Resection With Endo-knife and Snare for Colorectal Lesions: A Systematic Review and Meta-analysis 内镜下刀和圈套混合切除结直肠病变:系统回顾和荟萃分析
IF 2.4 Q3 Medicine Pub Date : 2023-01-01 DOI: 10.1016/j.tige.2022.12.003
Shinji Yoshii , Takefumi Kikuchi , Yuki Hayashi , Masahiro Nojima , Hiro-o Yamano , Hiroshi Nakase

Background and Aims

Hybrid endoscopic resection with an endo-knife and snare (HYB-ER) has been used to overcome the difficulties of endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD). This study clarified the role of HYB-ER in colorectal neoplasm treatment.

Methods

We searched PubMed, Web of Science, and the Cochrane Library up to May 2021. Pooled data of patients with non-pedunculated colorectal tumors treated with HYB-ER, EMR, and ESD were analyzed. The outcomes of en bloc resection rate, procedure time, and adverse events (perforation, bleeding, and recurrence) were compared across HYB-ER, EMR, and ESD groups.

Results

Twenty-four studies were included in this meta-analysis. The mean tumor sizes were 24.4, 19.9, and 30.3 mm in the HYB-ER, EMR, and ESD groups, respectively. The proportion of en bloc resections following HYB-ER in 1626 colorectal lesions was 82%, with perforation and postprocedural bleeding in 4% and 3% of the cases, respectively. HYB-ER was superior to EMR because of its higher proportion of en bloc resections (57% in EMR) and lower recurrence rates (2% with HYB-ER vs 12% with EMR), but the procedure time for HYB-ER (30.85 minutes) was longer than that for EMR (9.97 minutes) and significantly shorter than for ESD (56.6 minutes). According to meta-regression analysis of tumor size and location, there was no significant difference in the en bloc resection rate between HYB-ER and ESD.

Conclusion

HYB-ER significantly contributed to improve en bloc resection, with fewer recurrence events than EMR and faster procedure times than ESD, with similar en bloc resection and adverse events. Favorable indications for HYB-ER include colorectal lesions of 20-30 mm in size that are difficult to treat with EMR.

Systematic review registration: PROSPERO CRD42020209097.

背景和目的内镜下刀圈套器混合切除术(HYB-ER)已被用于克服内镜下黏膜切除术(EMR)和内镜下黏膜下剥离术(ESD)的困难。本研究阐明了HYB-ER在结直肠肿瘤治疗中的作用。方法截至2021年5月,我们搜索了PubMed、Web of Science和Cochrane图书馆。对接受HYB-ER、EMR和ESD治疗的非带蒂结直肠肿瘤患者的汇总数据进行分析。比较HYB-ER、EMR和ESD组的整体切除率、手术时间和不良事件(穿孔、出血和复发)的结果。结果本荟萃分析共纳入24项研究。HYB-ER、EMR和ESD组的平均肿瘤大小分别为24.4、19.9和30.3 mm。在1626例结直肠病变中,HYB-ER后整体切除的比例为82%,穿孔和术后出血分别占4%和3%。HYB-ER优于EMR,因为其整体切除率较高(EMR为57%),复发率较低(HYB-ER为2%,EMR为12%),但HYB-ER的手术时间(30.85分钟)比EMR(9.97分钟)长,明显短于ESD(56.6分钟)。根据肿瘤大小和位置的元回归分析,HYB-ER和ESD的整体切除率没有显著差异。结论HYB-ER有助于改善整体切除,复发事件比EMR少,手术时间比ESD快,整体切除和不良事件相似。HYB-ER的有利适应症包括大小为20-30毫米的结直肠病变,这些病变很难用EMR治疗。系统回顾注册:PROSPERO CRD42020209097。
{"title":"Hybrid Endoscopic Resection With Endo-knife and Snare for Colorectal Lesions: A Systematic Review and Meta-analysis","authors":"Shinji Yoshii ,&nbsp;Takefumi Kikuchi ,&nbsp;Yuki Hayashi ,&nbsp;Masahiro Nojima ,&nbsp;Hiro-o Yamano ,&nbsp;Hiroshi Nakase","doi":"10.1016/j.tige.2022.12.003","DOIUrl":"https://doi.org/10.1016/j.tige.2022.12.003","url":null,"abstract":"<div><h3>Background and Aims</h3><p><span>Hybrid endoscopic resection with an endo-knife and snare (HYB-ER) has been used to overcome the difficulties of </span>endoscopic mucosal resection<span><span> (EMR) and endoscopic submucosal dissection (ESD). This study clarified the role of HYB-ER in </span>colorectal neoplasm<span> treatment.</span></span></p></div><div><h3>Methods</h3><p>We searched PubMed, Web of Science, and the Cochrane Library up to May 2021. Pooled data of patients with non-pedunculated colorectal tumors treated with HYB-ER, EMR, and ESD were analyzed. The outcomes of en bloc resection rate, procedure time, and adverse events (perforation, bleeding, and recurrence) were compared across HYB-ER, EMR, and ESD groups.</p></div><div><h3>Results</h3><p>Twenty-four studies were included in this meta-analysis. The mean tumor sizes were 24.4, 19.9, and 30.3 mm in the HYB-ER, EMR, and ESD groups, respectively. The proportion of en bloc resections following HYB-ER in 1626 colorectal lesions was 82%, with perforation and postprocedural bleeding in 4% and 3% of the cases, respectively. HYB-ER was superior to EMR because of its higher proportion of en bloc resections (57% in EMR) and lower recurrence rates (2% with HYB-ER vs 12% with EMR), but the procedure time for HYB-ER (30.85 minutes) was longer than that for EMR (9.97 minutes) and significantly shorter than for ESD (56.6 minutes). According to meta-regression analysis of tumor size and location, there was no significant difference in the en bloc resection rate between HYB-ER and ESD.</p></div><div><h3>Conclusion</h3><p>HYB-ER significantly contributed to improve en bloc resection, with fewer recurrence events than EMR and faster procedure times than ESD, with similar en bloc resection and adverse events. Favorable indications for HYB-ER include colorectal lesions of 20-30 mm in size that are difficult to treat with EMR.</p><p>Systematic review registration: PROSPERO CRD42020209097.</p></div>","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49765352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum Regarding Declaration of Ethical Statements in Previously Published Articles 关于先前发表文章中伦理声明声明的勘误表
IF 2.4 Q3 Medicine Pub Date : 2022-01-01 DOI: 10.1016/j.tige.2022.03.004
{"title":"Erratum Regarding Declaration of Ethical Statements in Previously Published Articles","authors":"","doi":"10.1016/j.tige.2022.03.004","DOIUrl":"10.1016/j.tige.2022.03.004","url":null,"abstract":"","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767448/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10780064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hybrid APC Colon EMR, A Novel Approach to Reduce Local Recurrence 混合型APC结肠EMR,一种减少局部复发的新方法
IF 2.4 Q3 Medicine Pub Date : 2022-01-01 DOI: 10.1016/j.tige.2021.08.004
John M. Levenick , Andrew J. Groff , Carl Manzo , Courtney Lester , Jennifer L. Maranki

Background and Aims

Endoscopic mucosal resection (EMR) has become the standard for removing large colon polyps but has a 10%-30% recurrence rate using standard techniques. Data shows improved recurrence rates with focal therapy of the edge of the resection base using cautery. We examine a novel technique, hybrid APC assisted EMR, which treats both the edge and the base with cautery to assess its effect on local recurrence.

Methods

We reviewed all EMRs of polyps >2 cm by a single endoscopist with 6-month follow-up from May 2018 to November 2019 using both standard EMR as well as hybrid APC assisted EMR to assess local recurrence as well adverse events.

Results

Forty-eight patients with 59 polyps removed by EMR had full 6 month follow up with a mean age of 66.1 years of age, 45% were female. Thirty polyps were removed by hybrid APC assisted EMR and 29 removed with standard EMR. Overall, 0 (0%) polyps in the h-APC arm had local recurrence while 6 (20.7%) in the standard group had histological proven local recurrence (P = 0.01). Postresection bleeding occurred in 6 patients, 2 in the hAPC arm and 4 in the standard arm (P = 0.41).

Conclusion

In this retrospective pilot study, hybrid APC assisted EMR was superior to conventional EMR for local recurrence after removal of large colon polyps and trended towards a less post-EMR bleeds.

背景和目的内镜下粘膜切除术(EMR)已成为切除大结肠息肉的标准方法,但使用标准技术有10%-30%的复发率。资料显示病灶切除基底边缘烧灼治疗可提高复发率。我们研究了一种新技术,混合APC辅助EMR,它对边缘和基部进行烧灼治疗,以评估其对局部复发的影响。方法回顾2018年5月至2019年11月,由一名内镜医师随访6个月的所有2cm息肉的EMR,采用标准EMR和混合APC辅助EMR评估局部复发和不良事件。结果经EMR切除息肉59例48例,随访6个月,平均年龄66.1岁,其中女性占45%。混合APC辅助EMR切除息肉30例,标准EMR切除息肉29例。总体而言,h-APC组有0例(0%)息肉局部复发,而标准组有6例(20.7%)息肉组织学证实局部复发(P = 0.01)。术后出血6例,hAPC组2例,标准组4例(P = 0.41)。结论在这项回顾性的前期研究中,混合APC辅助EMR治疗大结肠息肉切除后局部复发优于传统EMR,且EMR术后出血倾向较少。
{"title":"Hybrid APC Colon EMR, A Novel Approach to Reduce Local Recurrence","authors":"John M. Levenick ,&nbsp;Andrew J. Groff ,&nbsp;Carl Manzo ,&nbsp;Courtney Lester ,&nbsp;Jennifer L. Maranki","doi":"10.1016/j.tige.2021.08.004","DOIUrl":"10.1016/j.tige.2021.08.004","url":null,"abstract":"<div><h3>Background and Aims</h3><p>Endoscopic mucosal resection (EMR) has become the standard for removing large colon polyps but has a 10%-30% recurrence rate using standard techniques. Data shows improved recurrence rates with focal therapy of the edge of the resection base using cautery. We examine a novel technique, hybrid APC assisted EMR, which treats both the edge and the base with cautery to assess its effect on local recurrence.</p></div><div><h3>Methods</h3><p>We reviewed all EMRs of polyps &gt;2 cm by a single endoscopist with 6-month follow-up from May 2018 to November 2019 using both standard EMR as well as hybrid APC assisted EMR to assess local recurrence as well adverse events.</p></div><div><h3>Results</h3><p>Forty-eight patients with 59 polyps removed by EMR had full 6 month follow up with a mean age of 66.1 years of age, 45% were female. Thirty polyps were removed by hybrid APC assisted EMR and 29 removed with standard EMR. Overall, 0 (0%) polyps in the h-APC arm had local recurrence while 6 (20.7%) in the standard group had histological proven local recurrence (<em>P</em> = 0.01). Postresection bleeding occurred in 6 patients, 2 in the hAPC arm and 4 in the standard arm (<em>P</em> = 0.41).</p></div><div><h3>Conclusion</h3><p>In this retrospective pilot study, hybrid APC assisted EMR was superior to conventional EMR for local recurrence after removal of large colon polyps and trended towards a less post-EMR bleeds.</p></div>","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.tige.2021.08.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127443683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Endoscopic Diagnosis of Portal Hypertension 门静脉高压的内镜诊断
IF 2.4 Q3 Medicine Pub Date : 2022-01-01 DOI: 10.1016/j.tige.2022.01.003
Alyssa Y. Choi, Kenneth J. Chang

Portal hypertension (PH), resulting from increased resistance of hepatic sinusoids to blood flow, is a severe complication of liver cirrhosis. The pathogenesis involves alteration of the liver vasculature due to fibrosis as well as increased production of vasoconstrictive mediators relative to endogenous vasodilators. Complications of PH include esophageal varices, gastric varices, portal hypertensive gastropathy, ascites, and hepatorenal syndrome. On endoscopy, the signs of portal hypertension include the presence of portal hypertensive gastropathy and/or esophageal/gastric varices. On Endoscopic Ultrasound (EUS), the liver parenchyma can be qualitatively and quantitatively assessed by imaging, “palpation,” as well as shear wave elastography. In addition, EUS can detect the presence of ascites, as well as intra and extra-mural dilated vessels that can be caused by PH. However, the most significant breakthrough for endoscopists is the ability to directly measure hepatic and portal vein pressures by means of EUS-guided portal pressure gradient (PPG) measurements. The endoscopic diagnosis of PH can be useful in determining the stage, progression, and prognosis of cirrhosis in individual patients.

门脉高压(PH)是肝硬化的一种严重并发症,由肝窦对血流的阻力增加引起。其发病机制包括肝纤维化引起的肝血管改变,以及相对于内源性血管扩张剂血管收缩介质的产生增加。PH的并发症包括食管静脉曲张、胃静脉曲张、门脉高压性胃病、腹水和肝肾综合征。在内窥镜检查中,门静脉高压的征象包括门静脉高压性胃病和/或食管/胃静脉曲张。在超声内镜(EUS)下,肝实质可以通过影像学、“触诊”和横波弹性成像进行定性和定量评估。此外,EUS可以检测腹水的存在,以及由ph引起的壁内和壁外血管扩张。然而,内窥镜医师最重要的突破是能够通过EUS引导的门静脉压力梯度(PPG)测量直接测量肝脏和门静脉压力。酸碱度的内窥镜诊断可用于确定个体患者肝硬化的分期、进展和预后。
{"title":"Endoscopic Diagnosis of Portal Hypertension","authors":"Alyssa Y. Choi,&nbsp;Kenneth J. Chang","doi":"10.1016/j.tige.2022.01.003","DOIUrl":"10.1016/j.tige.2022.01.003","url":null,"abstract":"<div><p><span><span>Portal hypertension (PH), resulting from increased resistance of </span>hepatic sinusoids<span><span> to blood flow, is a severe complication of liver cirrhosis<span>. The pathogenesis involves alteration of the liver vasculature<span> due to fibrosis as well as increased production of vasoconstrictive mediators relative to endogenous vasodilators. Complications of PH include </span></span></span>esophageal varices<span><span>, gastric varices, portal hypertensive gastropathy, </span>ascites<span>, and hepatorenal syndrome. On </span></span></span></span>endoscopy<span><span>, the signs of portal hypertension include the presence of portal hypertensive gastropathy and/or esophageal/gastric varices. On Endoscopic Ultrasound<span><span> (EUS), the liver parenchyma can be qualitatively and quantitatively assessed by imaging, “palpation,” as well as </span>shear wave elastography. In addition, EUS can detect the presence of ascites, as well as intra and extra-mural dilated vessels that can be caused by PH. However, the most significant breakthrough for endoscopists is the ability to directly measure hepatic and </span></span>portal vein pressures by means of EUS-guided portal pressure gradient (PPG) measurements. The endoscopic diagnosis of PH can be useful in determining the stage, progression, and prognosis of cirrhosis in individual patients.</span></p></div>","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122538392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
High-definition Probe-based Confocal Laser Endomicroscopy Review and Meta-analysis for Neoplasia Detection in Barrett's Esophagus 基于探针的高清晰度共聚焦激光内镜对Barrett食管肿瘤检测的回顾和荟萃分析
IF 2.4 Q3 Medicine Pub Date : 2022-01-01 DOI: 10.1016/j.tige.2022.06.001
Steven DeMeester , Kenneth Wang , Kamran Ayub , F. Paul Buckley , Philip Leggett , Paul Severson , Anastasia Chahine , Jason B. Samarasena

Background and Aims

The goal of this systematic review and meta-analysis was to assess the probe-based confocal laser endomicroscopy (pCLE) benefit as an adjunct to random four-quadrant biopsies in the surveillance of patients with Barrett's esophagus for dysplasia and early esophageal cancer (EAC) detection.

Methods

The MEDLINE and EMBASE databases were systematically searched for studies reporting pCLE detection rates and diagnostic accuracy for esophageal dysplasia and EAC. Three meta-analyses were performed to estimate pooled sensitivities (SEs), specificities (SPs), negative predictive values (NPVs), and per-patient pooled absolute and relative detection rate of neoplasia with 95% confidence intervals (CIs) to compare pCLE detection rate with that of random four-quadrant biopsies.

Results

A total of 9 studies were included (688 patients and 1299 lesions). Per-patient pCLE pooled SEs, SPs, and NPVs were 96% (95% CI 65%-100%), 93% (95% CI 71%-99%), and 98% (95% CI 93%-100%), respectively. Per-lesion pCLE pooled SEs, SPs, and NPVs were 82% (95% CI 63%-92%), 90% (95% CI 84%-94%), and 95% (95% CI 94%-97%), respectively. Compared with random biopsies, the per-patient pooled absolute and relative detection rate increases of neoplasia with pCLE were significant and equal to 5% (95% CI 1%-9%) and 243% (95% CI 122%-482%), respectively.

Conclusion

The addition of pCLE-guided biopsies provides a significantly higher diagnostic yield for dysplasia and cancer and reduces sampling error compared with random four-quadrant biopsies alone. Therefore, pCLE should be considered an important adjunct to Seattle protocol biopsies in patients undergoing screening or surveillance for Barrett's esophagus.

背景和目的本系统综述和荟萃分析的目的是评估基于探针的共聚焦激光内镜(pCLE)作为随机四象限活检的辅助手段在监测Barrett食管异常增生和早期食管癌(EAC)检测中的益处。方法系统检索MEDLINE和EMBASE数据库中有关pCLE对食管发育不良和EAC的检出率和诊断准确性的研究。进行了三项荟萃分析,以95%置信区间(ci)估计合并敏感性(SEs)、特异性(SPs)、阴性预测值(npv)和每位患者合并绝对和相对肿瘤检出率,并将pCLE检出率与随机四象限活检的检出率进行比较。结果共纳入9项研究(688例患者,1299个病灶)。每名患者pCLE汇总se、SPs和npv分别为96% (95% CI 65%-100%)、93% (95% CI 71%-99%)和98% (95% CI 93%-100%)。每个病灶的pCLE合并se、SPs和npv分别为82% (95% CI 63%-92%)、90% (95% CI 84%-94%)和95% (95% CI 94%-97%)。与随机活检相比,每名患者合并pCLE肿瘤的绝对检出率和相对检出率均显著增加,分别为5% (95% CI 1%-9%)和243% (95% CI 122%-482%)。结论与单独的随机四象限活检相比,pcle引导下的活检对异常增生和癌症的诊断率明显提高,并减少了抽样误差。因此,在接受巴雷特食管筛查或监测的患者中,pCLE应被视为西雅图方案活检的重要辅助。
{"title":"High-definition Probe-based Confocal Laser Endomicroscopy Review and Meta-analysis for Neoplasia Detection in Barrett's Esophagus","authors":"Steven DeMeester ,&nbsp;Kenneth Wang ,&nbsp;Kamran Ayub ,&nbsp;F. Paul Buckley ,&nbsp;Philip Leggett ,&nbsp;Paul Severson ,&nbsp;Anastasia Chahine ,&nbsp;Jason B. Samarasena","doi":"10.1016/j.tige.2022.06.001","DOIUrl":"10.1016/j.tige.2022.06.001","url":null,"abstract":"<div><h3>Background and Aims</h3><p>The goal of this systematic review<span><span><span> and meta-analysis was to assess the probe-based confocal laser endomicroscopy (pCLE) benefit as an adjunct to random four-quadrant biopsies in the surveillance of patients with </span>Barrett's esophagus for </span>dysplasia and early esophageal cancer (EAC) detection.</span></p></div><div><h3>Methods</h3><p>The MEDLINE and EMBASE databases were systematically searched for studies reporting pCLE detection rates and diagnostic accuracy for esophageal dysplasia and EAC. Three meta-analyses were performed to estimate pooled sensitivities (SEs), specificities (SPs), negative predictive values (NPVs), and per-patient pooled absolute and relative detection rate of neoplasia with 95% confidence intervals (CIs) to compare pCLE detection rate with that of random four-quadrant biopsies.</p></div><div><h3>Results</h3><p>A total of 9 studies were included (688 patients and 1299 lesions). Per-patient pCLE pooled SEs, SPs, and NPVs were 96% (95% CI 65%-100%), 93% (95% CI 71%-99%), and 98% (95% CI 93%-100%), respectively. Per-lesion pCLE pooled SEs, SPs, and NPVs were 82% (95% CI 63%-92%), 90% (95% CI 84%-94%), and 95% (95% CI 94%-97%), respectively. Compared with random biopsies, the per-patient pooled absolute and relative detection rate increases of neoplasia with pCLE were significant and equal to 5% (95% CI 1%-9%) and 243% (95% CI 122%-482%), respectively.</p></div><div><h3>Conclusion</h3><p>The addition of pCLE-guided biopsies provides a significantly higher diagnostic yield for dysplasia and cancer and reduces sampling error compared with random four-quadrant biopsies alone. Therefore, pCLE should be considered an important adjunct to Seattle protocol biopsies in patients undergoing screening or surveillance for Barrett's esophagus.</p></div>","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128376999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic Scoring System for T2 Invasion in Colorectal Cancer 内镜下结直肠癌T2浸润评分系统
IF 2.4 Q3 Medicine Pub Date : 2022-01-01 DOI: 10.1016/j.tige.2021.11.005
Akinori Sasaki , Ryoko Shimizuguchi , Akinari Takao , Satomi Shibata , Souichiro Natsume , Shin-ichiro Horiguchi , Daisuke Nakano , Tatsuro Yamaguchi , Koichi Koizumi

Background and Aims

The depth of tumor invasion in colorectal cancer (CRC), especially T1b or T2, is crucial in treatment decision-making. However, their differences are not well-characterized. Thus, this study aimed to investigate the predictive endoscopic findings in tumor invasion of CRC.

Methods

Data from patients with T1b or T2 CRCs resected endoscopically or surgically were reviewed retrospectively. The patients were divided into 2 groups: T1b (n = 298) and T2 (n = 267) tumor invasion. A scoring system was established based on the endoscopic findings in each group, and the accuracy of the system was assessed using a receiver-operating-characteristic (ROC) curve analysis.

Results

T2 invasion was predicted by tumor size, irregular bottom of depression, existence of depression, expansion appearance, convergency of folds, and erosion or white coat. The risk scoring system was developed using the regression coefficient values of the above variables. The area under the ROC curve was 0.894 (95% confidence interval, 0.868-0921). Cases with a score ≥4 had a high risk of T2 (sensitivity, 84.5%; specificity, 78.9%).

Conclusion

Our scoring system was useful for the diagnosis of T1b and T2, and a score ≥4 could predict T2 invasion. Additional studies are warranted to confirm these results before our scoring system can be applied clinically.

背景与目的结直肠癌(CRC),尤其是T1b或T2的肿瘤浸润深度是决定治疗方案的关键。然而,他们的差异并没有很好地描述。因此,本研究旨在探讨内镜对结直肠癌肿瘤侵袭的预测作用。方法回顾性分析经内镜或手术切除的T1b或T2 crc患者的资料。将患者分为两组:肿瘤侵袭的t1组(n = 298)和T2组(n = 267)。根据每组患者的内镜检查结果建立评分系统,并采用受试者-工作特征(ROC)曲线分析评估评分系统的准确性。结果肿瘤大小、凹陷底不规则、凹陷是否存在、肿大外观、皱褶会聚、糜烂或白大褂均可预测st2侵袭。利用上述变量的回归系数值建立风险评分系统。ROC曲线下面积为0.894(95%可信区间0.868-0921)。评分≥4分的患者T2风险高(敏感性为84.5%;特异性,78.9%)。结论该评分系统可用于T1b和T2的诊断,评分≥4分可预测T2的侵袭。在我们的评分系统应用于临床之前,需要进一步的研究来证实这些结果。
{"title":"Endoscopic Scoring System for T2 Invasion in Colorectal Cancer","authors":"Akinori Sasaki ,&nbsp;Ryoko Shimizuguchi ,&nbsp;Akinari Takao ,&nbsp;Satomi Shibata ,&nbsp;Souichiro Natsume ,&nbsp;Shin-ichiro Horiguchi ,&nbsp;Daisuke Nakano ,&nbsp;Tatsuro Yamaguchi ,&nbsp;Koichi Koizumi","doi":"10.1016/j.tige.2021.11.005","DOIUrl":"10.1016/j.tige.2021.11.005","url":null,"abstract":"<div><h3>Background and Aims</h3><p>The depth of tumor invasion in colorectal cancer (CRC), especially T1b or T2, is crucial in treatment decision-making. However, their differences are not well-characterized. Thus, this study aimed to investigate the predictive endoscopic findings in tumor invasion of CRC.</p></div><div><h3>Methods</h3><p>Data from patients with T1b or T2 CRCs resected endoscopically or surgically were reviewed retrospectively. The patients were divided into 2 groups: T1b (n = 298) and T2 (n = 267) tumor invasion. A scoring system was established based on the endoscopic findings in each group, and the accuracy of the system was assessed using a receiver-operating-characteristic (ROC) curve analysis.</p></div><div><h3>Results</h3><p>T2 invasion was predicted by tumor size, irregular bottom of depression, existence of depression, expansion appearance, convergency of folds, and erosion or white coat. The risk scoring system was developed using the regression coefficient values of the above variables. The area under the ROC curve was 0.894 (95% confidence interval, 0.868-0921). Cases with a score ≥4 had a high risk of T2 (sensitivity, 84.5%; specificity, 78.9%).</p></div><div><h3>Conclusion</h3><p>Our scoring system was useful for the diagnosis of T1b and T2, and a score ≥4 could predict T2 invasion. Additional studies are warranted to confirm these results before our scoring system can be applied clinically.</p></div>","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590030721000866/pdfft?md5=7bcf3d9f52bafd243f7c0bd19537eed0&pid=1-s2.0-S2590030721000866-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126399664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Critical Illness Cholangiopathy in COVID-19 Long-haulers COVID-19中的重症胆管病
IF 2.4 Q3 Medicine Pub Date : 2022-01-01 DOI: 10.1016/j.tige.2022.05.006
Nasir Saleem, Betty H. Li, Raj Vuppalanchi, Samer Gawrieh, Mark A. Gromski
{"title":"Critical Illness Cholangiopathy in COVID-19 Long-haulers","authors":"Nasir Saleem,&nbsp;Betty H. Li,&nbsp;Raj Vuppalanchi,&nbsp;Samer Gawrieh,&nbsp;Mark A. Gromski","doi":"10.1016/j.tige.2022.05.006","DOIUrl":"10.1016/j.tige.2022.05.006","url":null,"abstract":"","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123802/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9713762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Endoscopic Solutions for Colorectal Anastomotic Leaks 内镜治疗结直肠吻合口瘘
IF 2.4 Q3 Medicine Pub Date : 2022-01-01 DOI: 10.1016/j.tige.2021.09.001
Andrea Martina Guida , Giovanni Leonetti , Roberto Finizio , Fabrizio Montagnese , Cesare Efrati , Giorgia Sena , Andrea Divizia , Domenico Benavoli

Anastomotic leakage is the most important postoperative complication following colorectal anastomoses. Endoscopic techniques are newly implemented and are somewhat in between options that can be considered for the treatment of AL in selected cases. Aim of this literature review is to present, analyze, and synthesize material from diverse sources to provide a comprehensive summary of the endoscopic procedures available for the treatment of fistula following LAR for rectal cancer. A bibliographic search was carried out on Pubmed for articles published until 31th January 2021. Two hundred thirteen articles were screened and after a proper assessment thirty-four articles were left for the scopes of this narrative review. The most commonly applied endoscopic solutions are the transrectal vacuum-assisted closure (VAC), the Over-The-Scope clipping system (OTSC) and the OverStitch suturing system. They all seem to offer integrate solutions in the management of colorectal anastomotic leaks. Early detection of anastomotic leak might increase the success rate of endoscopic techniques, reducing overall healing time and length of hospital stay. Endoscopic evaluation could be added as an adjunctive screening test to all those patients who are suspected of an early postoperative colorectal leak, in order to confirm the suspicion and to promptly start the endoscopic treatment.

吻合口瘘是结直肠吻合术后最重要的并发症。内窥镜技术是新近实施的,在某些情况下可以考虑用于治疗AL的选择。本文献综述的目的是介绍、分析和综合来自不同来源的材料,以提供一个全面的总结,用于治疗直肠癌LAR后瘘的内镜手术。在Pubmed上对2021年1月31日之前发表的文章进行了书目检索。审查了213篇文章,经过适当评估后,留下34篇文章作为本叙述性审查的范围。最常用的内镜解决方案是经直肠真空辅助闭合(VAC),过镜夹系统(OTSC)和OverStitch缝合系统。它们似乎都提供了结肠直肠吻合口瘘管理的综合解决方案。早期发现吻合口瘘可以提高内镜技术的成功率,缩短整体愈合时间和住院时间。对于术后早期怀疑结直肠渗漏的患者,可增加内镜评估作为辅助筛查试验,以确认可疑并及时开始内镜治疗。
{"title":"Endoscopic Solutions for Colorectal Anastomotic Leaks","authors":"Andrea Martina Guida ,&nbsp;Giovanni Leonetti ,&nbsp;Roberto Finizio ,&nbsp;Fabrizio Montagnese ,&nbsp;Cesare Efrati ,&nbsp;Giorgia Sena ,&nbsp;Andrea Divizia ,&nbsp;Domenico Benavoli","doi":"10.1016/j.tige.2021.09.001","DOIUrl":"10.1016/j.tige.2021.09.001","url":null,"abstract":"<div><p><span>Anastomotic leakage is the most important </span>postoperative complication<span><span> following colorectal anastomoses<span>. Endoscopic techniques are newly implemented and are somewhat in between options that can be considered for the treatment of AL in selected cases. Aim of this literature review is to present, analyze, and synthesize material from diverse sources to provide a comprehensive summary of the endoscopic procedures available for the treatment of </span></span>fistula<span><span> following LAR for </span>rectal cancer. A bibliographic search was carried out on Pubmed for articles published until 31th January 2021. Two hundred thirteen articles were screened and after a proper assessment thirty-four articles were left for the scopes of this narrative review. The most commonly applied endoscopic solutions are the transrectal vacuum-assisted closure (VAC), the Over-The-Scope clipping system (OTSC) and the OverStitch suturing system. They all seem to offer integrate solutions in the management of colorectal anastomotic leaks. Early detection of anastomotic leak might increase the success rate of endoscopic techniques, reducing overall healing time and length of hospital stay. Endoscopic evaluation could be added as an adjunctive screening test to all those patients who are suspected of an early postoperative colorectal leak, in order to confirm the suspicion and to promptly start the endoscopic treatment.</span></span></p></div>","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.tige.2021.09.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124273136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Nonsurgical Gallbladder Drainage: Percutaneous and Endoscopic Approaches 非手术胆囊引流:经皮和内镜入路
IF 2.4 Q3 Medicine Pub Date : 2022-01-01 DOI: 10.1016/j.tige.2021.06.004
Gregory Toy MD , Douglas G. Adler MD, FACG, AGAF, FASGE

Acute cholecystitis is a common condition affecting 500,000 Americans per year. Although the gold standard treatment is cholecystectomy, some patients are poor surgical candidates requiring alternative treatment. Alternative treatment usually involves gallbladder drainage through a percutaneous or endoscopic approach. One common endoscopic approach is the transpapillary approach which involves cannulating the common bile duct and cystic duct sequentially and inserting a stent into the gallbladder. This technique can be technically challenging as the cystic duct can be difficult to cannulate and has a risk of postprocedure pancreatitis. However, this technique can be advantageous as it preserves a patient's anatomy for possible surgery in the future. The other common endoscopic approach is the transmural approach. This involves using an echoendoscope to determine an appropriate place to puncture the gallbladder and then using a needle and guidewire to create an opening to place a stent connecting the gallbladder and GI lumen. Use of a needle and guidewire can be obviated if an electrocautery method is used. This technique has an exceptionally high technical and clinical success rate but there is concern for stent occlusion and tissue overgrowth in long term stent placement. Technical and clinical success rates are similar between the percutaneous and transmural approaches which are higher than those in the transpapillary approach. Taken together, the endoscopic approaches are associated with shorter hospital stays and readmissions. Mortality rates are similar in all the approaches.

急性胆囊炎是一种常见疾病,每年影响50万美国人。虽然金标准治疗是胆囊切除术,但一些患者手术条件差,需要其他治疗方法。替代治疗通常包括经皮或内窥镜胆囊引流。一种常见的内窥镜入路是经乳头入路,它包括依次插管总胆管和胆囊管并将支架插入胆囊。这项技术在技术上具有挑战性,因为胆囊管很难插管,而且有术后胰腺炎的风险。然而,这种技术是有利的,因为它保留了病人的解剖结构,以便将来可能的手术。另一种常见的内镜入路是跨壁入路。这包括使用回声内窥镜确定一个合适的位置穿刺胆囊,然后使用针和导丝制造一个开口,放置连接胆囊和胃肠道管腔的支架。如果使用电灼法,可以避免使用针和导丝。该技术具有非常高的技术和临床成功率,但在长期支架放置中存在支架闭塞和组织过度生长的问题。经皮和经壁入路的技术和临床成功率相似,均高于经乳头入路。综上所述,内窥镜入路与较短的住院时间和再入院有关。所有方法的死亡率都差不多。
{"title":"Nonsurgical Gallbladder Drainage: Percutaneous and Endoscopic Approaches","authors":"Gregory Toy MD ,&nbsp;Douglas G. Adler MD, FACG, AGAF, FASGE","doi":"10.1016/j.tige.2021.06.004","DOIUrl":"10.1016/j.tige.2021.06.004","url":null,"abstract":"<div><p><span>Acute cholecystitis<span><span><span> is a common condition affecting 500,000 Americans per year. Although the gold standard treatment is </span>cholecystectomy<span><span>, some patients are poor surgical candidates requiring alternative treatment. Alternative treatment usually involves gallbladder drainage through a percutaneous or endoscopic approach. One common endoscopic approach is the transpapillary approach which involves cannulating the </span>common bile duct<span><span> and cystic duct sequentially and inserting a stent into the gallbladder. This technique can be technically challenging as the cystic duct can be difficult to cannulate and has a risk of postprocedure </span>pancreatitis. However, this technique can be advantageous as it preserves a patient's </span></span></span>anatomy<span><span> for possible surgery in the future. The other common endoscopic approach is the transmural approach. This involves using an echoendoscope to determine an appropriate place to puncture the gallbladder and then using a needle and guidewire to create an opening to place a stent connecting the gallbladder and GI lumen. Use of a needle and guidewire can be obviated if an electrocautery method is used. This technique has an exceptionally high technical and clinical success rate but there is concern for </span>stent occlusion and tissue overgrowth in long term </span></span></span>stent placement. Technical and clinical success rates are similar between the percutaneous and transmural approaches which are higher than those in the transpapillary approach. Taken together, the endoscopic approaches are associated with shorter hospital stays and readmissions. Mortality rates are similar in all the approaches.</p></div>","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.tige.2021.06.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123093946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Techniques and Innovations in Gastrointestinal Endoscopy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1